These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 606416)

  • 1. Treatment of patients with senile, post-menopausal and corticosteroid-induced osteoporosis with 1alpha-hydroxyvitamin D3 and calcium: short- and long-term effects.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():183s-189s. PubMed ID: 606416
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
    Lindgren U; Lindholm S; Sarby B
    Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Evaluation of bone histomorphometry in osteoporotics and age matched controls.
    Lindholm TS; Nilsson OS; Widhe T; Elmsted E; Eriksson S
    Acta Vitaminol Enzymol; 1982; 4(1-2):179-84. PubMed ID: 7124565
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Eriksson S
    Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
    Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Eriksson S; Lindholm TC
    Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women.
    Marshall DH; Nordin BE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():159s-168s. PubMed ID: 606414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
    Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
    Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
    Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
    Caniggia A; Vattimo A
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low dose regime of 1 alpha hydroxyvitamin D3 in the management of senile osteoporosis: a pilot study.
    Cohen HN; Farrah D; Fogelman I; Goll CC; Beastall GH; McIntosh WB; Fletcher M; Boyle IT
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):537-42. PubMed ID: 7398099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P; Dequeker J; Verstraeten A; Nijs J; Van Holsbeeck M
    Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
    Crilly R; Horsman A; Marshall DH; Nordin BE
    Aust N Z J Med; 1979 Feb; 9(1):24-30. PubMed ID: 313208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopenia in rheumatology practice: pathogenesis and therapy.
    Tannenbaum H
    Semin Arthritis Rheum; 1984 May; 13(4):337-48. PubMed ID: 6374899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced osteopenia.
    Hahn TJ
    Arch Intern Med; 1978 May; 138 Spec No():882-5. PubMed ID: 646579
    [No Abstract]   [Full Text] [Related]  

  • 17. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
    Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
    Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of therapeutic usefulness of vitamin D3 analogs on osteoporosis caused by ovariectomy in rats.
    Izawa Y; Sagara K; Kadota T; Makita T
    Acta Vitaminol Enzymol; 1985; 7(3-4):173-81. PubMed ID: 3841463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.